CA 72.4 / SERUM

image not found

NABL Cap Accredited 
The CA 72.4 test measures a tumor-associated antigen in serum and is primarily used as an additional marker in the evaluation and follow-up of gastric and other gastrointestinal cancers. While not used for screening, it can provide helpful information when interpreted with imaging and clinical findings. Metropolis Healthcare employs sensitive immunoassay procedures to deliver accurate and reproducible results. This test supports monitoring disease activity and assessing response to therapy in appropriate clinical scenarios.

 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,915.00

Sample Type: SERUM

Fasting Not Required


Notes: C0009

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CA 72.4 antigen levels in serum, performed with precision by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassay technology to detect and quantify CA 72.4 reliably.

Who should take this test?
Patients evaluated for or being monitored after gastrointestinal cancers can benefit at Metropolis Healthcare.

Can this test diagnose cancer on its own?
No, Metropolis Healthcare interprets this marker only in combination with imaging and clinical assessment.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs a serum sample.

What do elevated CA 72.4 levels indicate?
Elevated levels at Metropolis Healthcare may suggest malignancy or, less commonly, benign conditions.

How is this test used in monitoring?
Metropolis Healthcare uses this test to track treatment response and detect possible recurrence.

How long does it take to get results?
Metropolis Healthcare ensures timely reporting to support effective patient management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab